Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7];Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance

Radiologia Medica

Volumn 119, Issue 12, 2014, Pages 885-894

  Schicchi, Nicolò ^a   Valeri, Gianluca ^a   Moroncini, Gianluca ^a,b   Agliata, Giacomo ^b   Salvolini, Luca ^a   Gabrielli, Armando ^a,b   Giovagnoni, Andrea ^a  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Contrast enhanced cardiac MRI; Scleroderma

Indexed keywords

CONTRAST MEDIUM;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHIES; CARDIOVASCULAR SYSTEM; COMPLICATION; DIFFUSE SCLERODERMA; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHIES; CARDIOVASCULAR SYSTEM; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SCLERODERMA, DIFFUSE; SCLERODERMA, SYSTEMIC;

EID: 84912033864     PISSN: 00338362     EISSN: 18266983     Source Type: Journal    
DOI: 10.1007/s11547-014-0430-z     Document Type: Erratum

References (37)

1. Black CM, Denton CP (1998) Systemic sclerosis and related disorders in adults and children. In: Maddison PG, Isenberg DA, Woo P, Glass DN (eds) Oxford Textbook of Rheumatology, Oxford University Press, Inc. 2nd edn. vol 2, pp 1217–1247
2. Deswal A, Follansbee WP (1996) Cardiac involvement in scleroderma. Rheum Dis Clin North Am 22:841–860
3. Coghlan JG, Mukerjee D (2001) The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Curr Opin Rheumatol 13:495–499
4. Steen V (2004) The heart in systemic sclerosis. Curr Rheumatol Rep 6:137–140
5. Medsger TA Jr, Masi AT (1973) Survival with scleroderma-II. A life-table analysis of clinical and demographic factors in 358 male US veteran patients. J Chron Dis 26:647–660
6. Follansbee WP, Miller TR, Curtiss EL et al (1990) A controlled clinico-pathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 17:656–662
7. Marzullo P, Parodi O, Sambuceti G et al (1995) Myocardial viability: nuclear medicine versus stress echocardiography. Echocardiography 12:291–302
8. Valentini G, Vitale DF, Giunta A et al (1996) Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. Ann Rheum Dis 55:455–460
9. Armstrong GP, Whalley GA, Doughty RN et al (1996) Left ventricular function in scleroderma. Br J Rheumatol 35:983–988
10. Ferri C, Di Bello V, Martini A et al (1998) Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study. Ann Rheum Dis 57:296–302
11. Pennell D (2001) Imaging techniques. Cardiovascular magnetic resonance. Heart 85:581–589
12. Panting JR, Gatehouse PD, Yang GZ et al (2002) Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346:1948–1953
13. Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age and contractile function. Circulation 100:1992–2002
14. Karwatowski S, Chronos A, Sinclaire H et al (2000) Effect of systemic sclerosis on left ventricular long-axis motion and left ventricular mass assessed by magnetic resonance. J Cardiovasc Magn Reson 2:109–117
15. Moon J, Coghlan JG, Pennell DJ (2001) Systemic sclerosis involving the heart. Heart 86:308
16. Dziadzio M, Giovagnoni A, Pomponio G et al (2003) Acute myocarditis associated with adenoviral infection in a patient with scleroderma. Clin Rheumatol 22:487–490
17. Plastiras SC, Kelekis N, Tzelepis GE (2006) Magnetic resonance imaging for the detection of myocardial fibrosis in scleroderma. N Engl J Med 354:2194–2196
18. Tzelepis GE, Kelekis NL, Plastiras SC et al (2007) Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 56:3827–3836
19. Hachulla AL, Launay D, Gaxotte V et al (2009) Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 68:1878–1884
20. Kobayashi H, Yokoe I, Hirano M et al (2009) Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 36:106–112
21. Mavrogeni S, Bratis K, van Wijk K et al (2012) Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance. Int J Cardiol 159:e56–e58
22. Subcommitee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
23. LeRoy EC, Black CM, Fleishmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
24. Medsger TA Jr (2003) Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin N Am 29:255–273
25. Valentini G, Medsger TA Jr, Silman AJ, Bombardieri S (2003) Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 21(Suppl. 29):S47–S56
26. Appendix. Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc. Clin Exp Rheumatol 2003;21(Suppl.29):S49–S56
27. Ferri C, Emdin M, Nielsen H, Bruhlmann P (2003) Assessment of heart involvement. Clin Exp Rheumatol 21(Suppl. 29):S24–S28
28. Committee Guidelines (2003) European Society of hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21:1011–1053
29. Sahn DJ, De Maria A, Kissi S, Wayman A (1978) Recommendations regarding quantification in M-mode echocardiography: results of a series of echocardiographic measurements. Circulation 58:1072–1083
30. Barst RJ, McGoon M, Torbicki A et al (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. JACC 43(Suppl S):40S–47S
31. Lin CC, Ding HJ, Chen YW et al (2003) Usefulness of technetium-99m sestamibi myocardial perfusion SPECT in detection of cardiovascular involvement in patients with systemic lupus erythematosus or systemic sclerosis. Int J Cardiol 92:157–161
32. Nakajima K, Kawano M, Hasegawa M et al (2006) Myocardial damages in systemic sclerosis detected by gated myocardial perfusion SPECT and sympathetic imaging. Circ J 70:1481–1487
33. Sulli A, Ghio M, Bezante GP et al (2004) Blunted coronary flow reserve in systemic sclerosis. Rheumatology 43:505–509
34. D’Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46:428–440
35. Akram MR, Handler CE, Williams M et al (2006) Angiographically proven coronary artery disease in scleroderma. Rheumatology 45:1395–1398
36. Avouac J, Fransen J, Walker UA et al (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 70:476–481
37. Di Cesare E, Battisti S, Di Sibio A et al (2013) Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). Eur J Radiol 82:e268–e273